Ticker LaunchIPO · ERAS
Erasca, Inc.
Erasca, Inc. (ERAS) priced its initial public offering on Jul 16, 2021 at $16.00 per share, within its $14.00–$16.00 range, raising $300M, and listed on Nasdaq Global Select. At the IPO price its market capitalization was about $1.86B. J.P. Morgan was lead-left underwriter, joined by Morgan Stanley, BofA Securities and Evercore ISI and others. Latham & Watkins advised the company and Cooley advised the underwriters.
- Status
- IPO
- Ticker
- ERAS
- Exchange
- Nasdaq Global Select
- Priced
- Jul 16, 2021
- IPO price
- $16.00
- Price range
- $14.00–$16.00
- Raised
- $300M
- Market cap at IPO price
- $1.86B
- First filed
- Jun 25, 2021
- Underwriters
- J.P. Morgan, Morgan Stanley, BofA Securities, Evercore ISI and Guggenheim
- Company counsel
- Latham & Watkins
- Underwriters' counsel
- Cooley
- Sector
- Biotech & pharma
- Country / state
- CA
Market cap at IPO price = shares outstanding after the offering (all classes, before the over-allotment option) × the IPO price, from the final prospectus.
More on this listing for subscribers
- Lock-up period and expiry date
- Shares offered, over-allotment and shares outstanding after the offering
Every record in the database also has its full filing timeline, a daily-updated calendar, watchlist alerts and Excel export.
Then $99/month or $999/year. Cancel anytime.
Filings
- Registration statement (S-1) first filed Jun 25, 2021
- Latest amendment Jul 12, 2021
- Final prospectus (424B4) Jul 16, 2021
- All filings on EDGAR CIK 1761918
Other Biotech & pharma IPOs in 2021
- Absci CorpABSI · Jul 23, 2021 · $200M
- HCW Biologics Inc.HCWB · Jul 21, 2021 · $56M
- Regencell Bioscience Holdings LtdRGC · Jul 20, 2021 · $21.9M
- TScan Therapeutics, Inc.TCRX · Jul 19, 2021 · $100M
- Imago BioSciences, Inc.IMGO · Jul 16, 2021 · $134.4M
- Unicycive Therapeutics, Inc.UNCY · Jul 14, 2021 · $25M